top of page

La Notizia


MOOC on gene and gene-based cell therapies for rare diseases
Foundation For Rare Diseases (Fondation Maladies Rares, France) organises an online MOOC on gene and gene-based cell therapies for rare diseases . Foundation For Rare Diseases (Fondation Maladies Rares, France) organises an online MOOC on gene and gene-based cell therapies for rare diseases . The course features contributions from leading U.S. and European researchers — including Alain Fischer, Heather Gray Edwards, Alessio Cantore, Zoltan Ivics, Sylvie Odent, Salima Ha
5 giorni fa


In memoria del Professor Claudio Bordignon
SITGEC è profondamente addolorata per la scomparsa del Professor Claudio Bordignon.
1 apr


FDA approval of the Biologics License Application (BLA) for Waskyra, the first gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS)
SITGEC would like to congratulate Fondazione Telethon and HSR-TIGET on the milestone achievement of the FDA approval of WAS ex vivo gene therapy. Please see below their statement: We are honoured to share a moment of profound significance for us, for patients, families, and the scientific community. The U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Waskyra , the first gene therapy for the treatment of Wiskott-Aldrich syn
10 dic 2025


EMBO Workshop titled “CRISPR-Cas: from biology to therapeutic applications” Sorrento
We would like to bring to your attention the upcoming EMBO Workshop titled “CRISPR-Cas: from biology to therapeutic applications”,...
23 mag 2025


Fondazione Telethon announces submission of MAA to EMA for Gene Therapy for the treatment of Wiskott-Aldrich Syndrome patients
Read the press release here for full details.
5 feb 2025


SITGEC 2024 Headline Numbers
See a summary of SITGEC's headline numbers from 2024.
6 gen 2025


School Event at the ESGCT and SITGEC 2024 Annual Congress
More than 1000 school students attended an event organised by Fondazione Telethon at the ESGCT/SITGEC Congress. Watch the event video here.
4 nov 2024
bottom of page